What are biosimilars?

Essential steps to help health systems better prepare for disruptions.

By McKesson Health Systems Editorial Team

Date

February 14, 2022

By: McKesson MedSurg Editorial Team

Read time: 5 minutes

There are important differences between biosimilars and biologics. research and studies show that the use of biosimilar drugs can save money for both patients and providers, and increased affordability of biosimilars can have a meaningful impact on the healthcare system.

To dive deeper into the differences, examining the costs and benefits, Derek Burns and Tim Ho, clinical specialists at McKesson, share their insights on biosimilars and discuss their expert knowledge of these new products.

People networking in a bright atrium, standing by glass railings and talking in small groups.

Upcoming Event: Navigating the Future of Specialty Pharmacy at AXS26

Connect with our industry leaders at Asembia to discover strategies to help you achieve more.

Five people seated around a conference table reviewing documents and charts during a meeting in a bright office.

Upcoming Event: Becker’s 16th Annual Meeting

McKesson leaders attending a C-suite roundtable on optimizing pharmaceutical supply chain and inventory management.

Four business professionals in a bright glass hallway, two standing and talking while others walk past, with city buildings visible through the windows.

Event Recap: 2026 340B Coalition Winter Conference Highlights

At this year's event, our experts engaged with health system leaders to address the growing need for strategic alignment and specialized support in 340B program management.

Close-up of an IV drip chamber with clear fluid flowing through tubing, with gloved hands and a clinical setting in the background.

Inside the Growth of Infusion Care: What’s Driving Demand—and How Health Systems Can Keep Pace

Empowering health systems to expect more from their infusion programs—and achieve more for every patient.

A pharmacist organizes prescription bottles on a rack

Four Key Aspects of Generic Drugs

Key aspects of generic drugs that support the case for wider adoption in health systems and beyond.

A stack of papers with pages highlighted rests on a desk next to an open laptop computer.

Top Prescribed Perspectives Reads for January

The top three Prescribed Perspectives articles downloaded by health systems in January.

Professionals talking in a modern office hallway, with two people walking together in the foreground and others conversing in the background.

Achieve More with McKesson at the 340B Coalition Winter Conference

Strategic guidance from trusted advisors to help your health system achieve more.

Healthcare professional showing a prescription bottle to a seated patient with another person standing nearby.

Expert Insights: Strengthening Care Delivery with Specialty Pharmacy Integration

Our Specialty Pharmacy Enablement expert shares insights on how health systems can boost access and outcomes by adopting integrated in‑house specialty pharmacy services.

Four professionals walking together through a modern office lobby, carrying bags and talking.

Explore How McKesson Collaborated with Customers at the 2025 ASHP Midyear Clinical Meeting

Experts shared strategic insights to help health systems achieve more for the business of pharmacy.

People in business attire sit in rows with a visible text reading “Advancing Infusion Care Through Access and Innovation.”

Expert Insights: Advancing Infusion Care Through Access and Innovation

Hear from our experts on how smarter scheduling and technology strengthen patient experience in health system infusion centers.

What are biosimilars?

Related Stories

Related Tags

Related Tags